Modeling the West Nile virus transfusion transmission risk in a nonoutbreak country associated with traveling donors
- PMID: 32869276
- DOI: 10.1111/trf.16060
Modeling the West Nile virus transfusion transmission risk in a nonoutbreak country associated with traveling donors
Abstract
Background: West Nile virus (WNV) is a mosquito-borne virus and transfusion transmission (TT) has been demonstrated. The European Union and neighboring countries experience an annual transmission season.
Study design and methods: We developed a novel probabilistic model to estimate the WNV TT risk in Australia attributable to returned donors who had travelled to the European Union and neighboring countries during the 2018. We estimated weekly WNV TT risks in Australia for each outbreak country and the cumulative risk for all countries.
Results: Highest mean weekly TT risk in Australia attributable to donors returning from a specific outbreak country was 1 in 23.3 million (plausible range, 16.8-41.9 million) donations during Week 39 in Croatia. Highest mean weekly cumulative TT risk was 1 in 8.5 million donations (plausible range, 5.1-17.8 million) during Week 35.
Conclusions: The estimated TT risk in Australia attributable to returning donors from the European Union and neighboring countries in 2018 was very small, and additional risk mitigation strategies were not indicated. In the context of such low TT risks, a simpler but effective approach would be to monitor the number of weekly reported West Nile fever cases and implement risk modeling only when the reported cases reached a predefined number or trigger point.
Keywords: Australia; West Nile virus; modelling; transfusion transmission risk.
© 2020 AABB.
References
REFERENCES
-
- Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012;25:635-648.
-
- European Center for Disease for Disease Prevention and Control. West Nile virus fever maps. Historical data. http://ecdc.europa.eu/en/healthtopics/west_nile_fever/West-Nile-fever-ma.... Accessed December 13, 2019.
-
- Pisani G, Cristiano K, Pupella S, Liumbruno GM. West Nile virus in Europe and safety of blood transfusion. Transfus Med Hemother. 2016;43:158-167.
-
- Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009;49:278-288.
-
- Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010;202:1354-1361.